LMNL-6326

N/A

Report date: 2023/08/11 10:08:28
NME

Base Information

Drug NameLMNL-6326
Drug Alias NameLMNL-6326LMNL6326
ClassificationSmall molecules
Mechanisms of Actionoxoeicosanoid receptor 1 antagonists
Targetsoxoeicosanoid receptor 1
Therapy Area/IndicationsDermatitis, AtopicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLiminal Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesLiminal Biosciences Inc
Inactive CompaniesN/A
Active IndicationsDermatitis, AtopicAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A